Related references
Note: Only part of the references are listed.Association between autoantibodies in systemic sclerosis and cancer in a national registry
Sabrina Hoa et al.
RHEUMATOLOGY (2022)
Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: Data from the Spanish Scleroderma Registry (RESCLE)
Cristina Carbonell et al.
AUTOIMMUNITY REVIEWS (2022)
Rapidly progressive interstitial lung disease under FOLFOX treatment for colorectal cancer associated with systemic sclerosis: two case reports
Samar El-Hout et al.
RHEUMATOLOGY (2021)
Presence of anti-TIF-1γ, anti-Ro52, anti-SSA/Ro60 and anti-Su/Ago2 antibodies in breast cancer: a cross-sectional study
Monica Vazquez-Del Mercado et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2021)
Systemic sclerosis: Recent insight in clinical management
Elisabetta Zanatta et al.
JOINT BONE SPINE (2020)
Using Autoantibodies and Cutaneous Subset to Develop Outcome-Based Disease Classification in Systemic Sclerosis
Svetlana I. Nihtyanova et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Biphasic Temporal Relationship between Cancers and Systemic Sclerosis: A Clinical Series from Montpellier University Hospital and Review of the Literature
Leo Partouche et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Autoantibodies to stratify systemic sclerosis patients into clinically actionable subsets
Michael Mahler et al.
AUTOIMMUNITY REVIEWS (2020)
The associations of interstitial lung abnormalities with cancer diagnoses and mortality
Gisli T. Axelsson et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Cancer and Scleroderma
Emma Weeding et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2020)
Cancer risk in systemic sclerosis: identifying risk and managing high-risk patients
George E. Fragoulis et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2020)
Thyroid cancer associated with Hashimoto thyroiditis: similarities and differences in an endemic area
Osama Hussein et al.
JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE (2020)
Intriguing Relationships Between Cancer and Systemic Sclerosis: Role of the Immune System and Other Contributors
Alexandre Thibault Jacques Maria et al.
FRONTIERS IN IMMUNOLOGY (2019)
Gene Profiling in Patients with Systemic Sclerosis Reveals the Presence of Oncogenic Gene Signatures
Marzia Dolcino et al.
FRONTIERS IN IMMUNOLOGY (2018)
A review of the role and clinical utility of anti-Ro52/TRIM21 in systemic autoimmunity
Adrian Y. S. Lee
RHEUMATOLOGY INTERNATIONAL (2017)
Mapping and predicting mortality from systemic sclerosis
Muriel Elhai et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Novel risk factors related to cancer in scleroderma
David Bernal-Bello et al.
AUTOIMMUNITY REVIEWS (2017)
Inflammation and cancer: tissue regeneration gone awry
Marina Pesic et al.
CURRENT OPINION IN CELL BIOLOGY (2016)
Cancer and scleroderma: a paraneoplastic disease with implications for malignancy screening
Ami A. Shah et al.
CURRENT OPINION IN RHEUMATOLOGY (2015)
Immunity, inflammation, and cancer: an eternal fight between good and evil
Shabnam Shalapour et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Cancer-Induced Autoimmunity in the Rheumatic Diseases
Ami A. Shah et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Association of the Autoimmune Disease Scleroderma with an Immunologic Response to Cancer
Christine G. Joseph et al.
SCIENCE (2014)
Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma
Pia Moinzadeh et al.
ARTHRITIS RESEARCH & THERAPY (2014)
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative
Frank van den Hoogen et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Clinical associations of anti-SSA/Ro60 and anti-Ro52/TRIM21 antibodies: Diagnostic utility of their separate detection
Aurora Menendez et al.
AUTOIMMUNITY (2013)
Systemic sclerosis (scleroderma) and cancer risk: systematic review and meta-analysis of observational studies
Martina Bonifazi et al.
RHEUMATOLOGY (2013)
Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis
Marie Hudson et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Cancer and systemic sclerosis: novel insights into pathogenesis and clinical implications
Ami A. Shah et al.
CURRENT OPINION IN RHEUMATOLOGY (2011)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
Anthony J. Tyndall et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Close Temporal Relationship Between Onset of Cancer and Scleroderma in Patients With RNA Polymerase I/III Antibodies
Ami A. Shah et al.
ARTHRITIS AND RHEUMATISM (2010)
Squamous Cell Carcinomas in 2 Patients with Diffuse Scleroderma Treated with Mycophenolate Mofetil
Aliya Gulamhusein et al.
JOURNAL OF RHEUMATOLOGY (2009)
Clinical significance of anti-Ro/SSA-52 kDa antibodies-a retrospective monocentric study
Baptiste Hervier et al.
RHEUMATOLOGY (2009)
The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis?
Antje Moeller et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Risk of malignancy in scleroderma - A population-based cohort study
S Chatterjee et al.
ARTHRITIS AND RHEUMATISM (2005)
Risk of cancer in patients with scleroderma: a population based cohort study
CL Hill et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Share Paper
